REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on the operation of Directive 2011/24/EU on the application of patients' rights in cross-border healthcare
1. The European Commission has submitted to the European Parliament and the Council a report on the application of patients’ rights in cross-border healthcare to facilitate the access to safe and high-quality healthcare in another Member State. The Directive sets out provisions for patients to be reimbursed for treatment abroad, in some cases under pre-authorisation requirements, and supported by non-discriminatory pricing (charging) and the establishment of national contact points (NCPs). Also, in the spirit of cross-border cooperation between Member States for the benefit of European Union citizens, the Directive covered the mutual recognition of prescriptions, digital health (eHealth), rare diseases and health technology assessments (HTAs). As required, the United Kingdom transposed the Directive on 25 October 2013.
2. The Commission’s report identified four priority areas for assessing compliance, as follows:
a. systems of reimbursement of costs for cross-border healthcare;
b. prior authorisation;
c. administrative procedures regarding cross-border healthcare; and
d. fees for patients from other Member States.